Cargando…
Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
Gene therapy has emerged as a powerful tool to treat various diseases, such as cardiovascular diseases, neurological diseases, ocular diseases and cancer diseases. In 2018, the FDA approved Patisiran (the siRNA therapeutic) for treating amyloidosis. Compared with traditional drugs, gene therapy can...
Autores principales: | Lin, Meng, Qi, Xianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220631/ https://www.ncbi.nlm.nih.gov/pubmed/37242692 http://dx.doi.org/10.3390/pharmaceutics15051450 |
Ejemplares similares
-
Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy
por: Zhang, Xintong, et al.
Publicado: (2023) -
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
por: Jia, Ruixin, et al.
Publicado: (2021) -
The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges
por: He, Jiaxi, et al.
Publicado: (2020) -
Recent Advances in Stimuli-Responsive Doxorubicin Delivery Systems for Liver Cancer Therapy
por: Radu, Elena Ruxandra, et al.
Publicado: (2022) -
Extracellular Vesicles as Delivery Vehicles for Therapeutic Nucleic Acids in Cancer Gene Therapy: Progress and Challenges
por: Du, Rong, et al.
Publicado: (2022)